Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Centre Oscar Lambret
Washington University School of Medicine
Dana-Farber Cancer Institute
Washington University School of Medicine
Centre hospitalier de l'Université de Montréal (CHUM)
National Cancer Institute (NCI)
Seagen Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Fudan University
SOFIE
Eli Lilly and Company
University of Wisconsin, Madison
University Hospital Heidelberg
Tianjin Medical University Cancer Institute and Hospital
University of Michigan Rogel Cancer Center
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Bayer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Merck Sharp & Dohme LLC
Neonc Technologies, Inc.
ViroMissile, Inc.
Duke University
Jazz Pharmaceuticals
Arcus Biosciences, Inc.
Tianjin Medical University Cancer Institute and Hospital
Zhejiang University
Jiangsu Cancer Institute & Hospital
Jazz Pharmaceuticals
Seagen Inc.
Qurient Co., Ltd.
University Hospital, Antwerp
AstraZeneca
UNC Lineberger Comprehensive Cancer Center
AstraZeneca
Intima Bioscience, Inc.
Duke University
Cedars-Sinai Medical Center
UMC Utrecht
National Cancer Institute (NCI)
KU Leuven
Essen Biotech
Institute of Oncology Ljubljana
Genentech, Inc.
Taipei Veterans General Hospital, Taiwan
KU Leuven
University of California, San Diego